INS and diabetes mellitus: RPG represents an FDA-approved drug for the treatment of type 2 diabetes mellitus (DM) [43], that rapidly lowers blood glucose levels by stimulating the insulin release from the pancreas through inhibition of the KATP channel activity [44].